Cetera Trust Company N.A purchased a new position in shares of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND – Free Report) during the 4th quarter, according to its most recent 13F filing with the SEC. The firm purchased 2,205 shares of the biotechnology company’s stock, valued at approximately $157,000. Several other institutional investors and hedge funds have also […]
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Shares Purchased by Impax Asset Management Group plc themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Impax Asset Management Group plc Acquires 20,888 Shares of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Ligand Pharmaceuticals (NASDAQ:LGND – Get Free Report) updated its FY 2024 earnings guidance on Tuesday. The company provided earnings per share guidance of 4.250-4.750 for the period, compared to the consensus earnings per share estimate of 4.270. The company issued revenue guidance of $130.0 million-$142.0 million, compared to the consensus revenue estimate of $138.5 million. […]
Ligand Pharmaceuticals (NASDAQ:LGND) Updates FY 2024 Earnings Guidance themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.